Clinical experience in the treatment of lower respiratory tract infections with ceftazidime.
In this study we report our results on the efficacy of ceftazidime in the treatment of 15 patients with lower respiratory tract infections. Most patients were elderly and had underlying diseases. Eleven patients were cured and one improved. In two cases the treatment was stopped after a few days because of local pain and in one patient a bacteriological failure was noted. Possible side-effects were noted in four cases: skin rash in one, local pain in two and transient rise in liver enzymes in one.
Pettersson
T
T
Department of Medicine, Aurora Hospital, Helsinki, Finland.
Ahvonen
P
P
Storgårds
E
E
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001991:Bronchitis / Q000188:drug therapy / Q000382:microbiology; D002442:Ceftazidime / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging; D008297:Male; D008875:Middle Aged; D018410:Pneumonia, Bacterial / Q000188:drug therapy / Q000382:microbiology; D011859:Radiography; D012141:Respiratory Tract Infections / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000382:microbiology; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D002442:Ceftazidime